Skip to main content
Premium Trial:

Request an Annual Quote

Ion Torrent Extends Grant Program to Europe

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ion Torrent today said that it will extend its sequencing grant program to Europe in the second half of this year.

The Guilford, Conn.-based firm said that under the grant program it will award two of its Personal Genome Machine sequencers to scientists in Europe.

The program is an extension of a grant program announced earlier this year, under which the firm said that it would award two sequencers to researchers in the US. The two initial winners, announced in April included Mitchell Sogin, director of the Josephine Bay Paul Center for Comparative Molecular Biology and Evolution, and John Iafrate and Long Phi Le of Massachusetts General Hospital.

As with the American award winners, those in Europe will be granted either the Dr. James Watson Healthcare Grant for a proposal in human health or the Dr. Gordon Moore Environment Grant for a proposal that addresses environmental, ecological, or evolutionary issues.

In addition to being awarded an Ion Torrent PGM sequencer, grant winners also will receive a perpetual license to the DNAStar SeqMan NGen assembly software and CLC Bio Genomics Workbench bioinformatics software.

Ion Torrent's PGM uses massively parallel semiconductor sequencing that detects nucleotide additions — without using light, optics, or lasers — by detecting the release of hydrogen ions after nucleotide incorporation. The firm unveiled the $50,000 sequencer earlier this year at the Advances in Genome Biology and Technology conference in Marco Island, Fla.

The firm said that researchers can apply for the grants on its website.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.